About the Partnership for Safe Medicines India
The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit www.safemedicinesindia.in
PSM LOGO 17th January
News Archive
Quote of the day
Bejan Misra"Human Rights aren't just about violence and terrorism. Unsafe drugs too fall into the category. TheNational Human Rights Commission (NHRC) has described the manufacture, distribution and sale of unsafe drugs and medical devices as a violation of human rights." --Mr. Bejon Misra (Founder, PSM India)
In other News
DANGEROUS AYURVEDIC PRODUCTS

Out of 244 samples of ayurvedic medicines sent to KEM’s Ayurveda Research Centre (ARC) over the past five years, 39.34% were found to contain steroids like betamethasone, dexamethasone and prednisolone.

This information was divulged in response to an RTI application filed by a chemical consultant and RTI activist, Dr. A. Shenoy, who alleges that many doctors add steroids to ayurvedic extracts to effect speedy cures. These adulterated substances, sold as remedies, may bring instant relief, but gradually lead to conditions like chest pain, nervousness, weight gain and swollen joints, Dr. Shenoy contends.

Read more

Follow US on Faceboook
Follow US on twitter
This Newsletter brought to you by

Abbott Logo

National News
SPURIOUS DRUG MAKERS ARRESTED
SindoorTwo individuals charged with making and supplying spurious ayurvdedic medicines have been arrested, one from Badayun district, Uttar Pradesh, and the other from Red Fort, Delhi.
Read More
HOSPITAL ACCUSED OF NEGLIGENCE
Twenty-one year old Deepti Makhijani died following a blood transfusion she underwent at Jaslok Hospital in which she was given B+ instead of A+ blood.
Read More
NATIONAL RURAL HEALTH MISSION UNDER CBI SCANNER

A probe into drug purchases of the National Rural Health Mission by the Central Bureau of Investigation has uncovered massive irregularities.

Read More
Global News
IRE AGAINST SPURIOUS DRUGS IN SIND, PAKISTAN
A discussion in the Sind Assembly on the manufacture and sale of spurious drugs in Sind, Pakistan, witnessed members of the assembly asserting that the drug regulatory authority, which rests with the federal government, should be devolved to the province after the 18th Amendment.
Read More
POTENTIALLY HARMFUL BLOOD PRESSURE MEDICINE
Rasilez is a blood pressure medicine authorized for use in Canada either independently or in combination with other drugs such as ACE-inhibitors and ARBs.
Read More
FDA GUIDELINES FOR DRUG USE
A given drug can have therapeutic uses apart from those approved by the Food and Drug Administration (FDA). These alternative drug uses – which are not indicated on the drug labels - can be important in patient care.
Read More
Pharma News
NEW GENERIC HYPERTENSION MEDICINE APPROVED BY FDA
Mylan Pharmaceuticals Inc. is marketing a generic version of a branded hypertension medicine of Abbott Laboratories.
Read More
INDIAN PHARMACEUTICAL COMPANIES IN THE GENERIC DRUG TRADE
Indian pharmaceutical companies are poised to manufacture generic medicines in a big way. Out of 548 ANDAs approved by the FDA in 2011, as many as 193 were garnered by 28 Indian companies.
Read More
Drug Laws and Policy News
LOW COST MEDICINES IN THE OFFING

A Planning Commission proposal, backed by the Health Ministry, seeks to make free drugs available at the government’s Public Health Facilities.

Read More
ILLEGAL DRUG TRIALS LAND TWO DOCTORS IN SOUP
Two senior doctors attached to MY Hospital, Indore, have earned the ire of the Drug Controller General of India (DCGI) for having carried out a trial of the male erectile-dysfunction medicine Tadlafil without first getting the DCGI’s permission to do so.
Read More
Send in your news contribution and valuable feedback to THE EDITOR at
pooja@safemedicinesindia.in
Pooja Khaitan
© 2011 Partnership for Safe Medicines India E-15/A, first floor, East of Kailash, New Delhi -110065
www.safemedicinesindia.in; www.safemedicines.org; Consumer Conexion